Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
23
06
2021
accepted:
16
05
2022
pubmed:
14
6
2022
medline:
24
9
2022
entrez:
13
6
2022
Statut:
ppublish
Résumé
Racial disparities in breast cancer care have been linked to treatment delays. We explored whether receiving care at a comprehensive breast center could mitigate disparities in time to treatment. Retrospective chart review identified breast cancer patients who underwent surgery from 2012 to 2018 at a comprehensive breast center. Time-to-treatment intervals were compared among self-identified racial and ethnic groups by negative binomial regression models. Overall, 2094 women met the inclusion criteria: 1242 (59%) White, 262 (13%) Black, 302 (14%) Hispanic, 105 (5%) Asian, and 183 (9%) other race or ethnicity. Black and Hispanic patients more often had Medicaid insurance, higher American Society of Anesthesiologists (ASA) scores, advanced-stage breast cancer, mastectomy, and additional imaging after breast center presentation (p < 0.05). After controlling for other variables, racial or ethnic minority groups had consistently longer intervals to treatment, with Black women experiencing the greatest disparity (incidence rate ratio 1.42). Time from initial comprehensive breast center visit to treatment was also significantly shorter in White patients versus non-White patients (p < 0.0001). Black race, Medicaid insurance/being uninsured, older age, earlier stage, higher ASA score, undergoing mastectomy, having reconstruction, and requiring additional pretreatment work-up were associated with a longer time from initial visit at the comprehensive breast center to treatment on multivariable analysis (p < 0.05). Racial or ethnic minority groups have significant delays in treatment even when receiving care at a comprehensive breast center. Influential factors include insurance delays and necessity of additional pretreatment work-up. Specific policies are needed to address system barriers in treatment access.
Sections du résumé
BACKGROUND
BACKGROUND
Racial disparities in breast cancer care have been linked to treatment delays. We explored whether receiving care at a comprehensive breast center could mitigate disparities in time to treatment.
METHODS
METHODS
Retrospective chart review identified breast cancer patients who underwent surgery from 2012 to 2018 at a comprehensive breast center. Time-to-treatment intervals were compared among self-identified racial and ethnic groups by negative binomial regression models.
RESULTS
RESULTS
Overall, 2094 women met the inclusion criteria: 1242 (59%) White, 262 (13%) Black, 302 (14%) Hispanic, 105 (5%) Asian, and 183 (9%) other race or ethnicity. Black and Hispanic patients more often had Medicaid insurance, higher American Society of Anesthesiologists (ASA) scores, advanced-stage breast cancer, mastectomy, and additional imaging after breast center presentation (p < 0.05). After controlling for other variables, racial or ethnic minority groups had consistently longer intervals to treatment, with Black women experiencing the greatest disparity (incidence rate ratio 1.42). Time from initial comprehensive breast center visit to treatment was also significantly shorter in White patients versus non-White patients (p < 0.0001). Black race, Medicaid insurance/being uninsured, older age, earlier stage, higher ASA score, undergoing mastectomy, having reconstruction, and requiring additional pretreatment work-up were associated with a longer time from initial visit at the comprehensive breast center to treatment on multivariable analysis (p < 0.05).
CONCLUSION
CONCLUSIONS
Racial or ethnic minority groups have significant delays in treatment even when receiving care at a comprehensive breast center. Influential factors include insurance delays and necessity of additional pretreatment work-up. Specific policies are needed to address system barriers in treatment access.
Identifiants
pubmed: 35697955
doi: 10.1245/s10434-022-11971-w
pii: 10.1245/s10434-022-11971-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6692-6703Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. Society of Surgical Oncology.
Références
DeSantis CE, et al. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017;67(6):439–48.
doi: 10.3322/caac.21412
Wheeler SB, Reeder-Hayes KE, Carey LA. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist. 2013;18(9):986–93.
doi: 10.1634/theoncologist.2013-0243
Newman LA, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer. 2002;94(11):2844–54.
doi: 10.1002/cncr.10575
Newman LA, et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer. 2002;95(1):21–7.
doi: 10.1002/cncr.10639
McAlearney AS, et al. The Challenge of improving breast cancer care coordination in safety-net hospitals: barriers, facilitators, and opportunities. Med Care. 2016;54(2):147–54.
doi: 10.1097/MLR.0000000000000458
Doubeni CA, Simon M, Krist AH. Addressing systemic racism through clinical preventive service recommendations from the US preventive services task force. JAMA. 2021;325(7):627–8.
doi: 10.1001/jama.2020.26188
Bleicher RJ, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–9.
doi: 10.1001/jamaoncol.2015.4508
Maloney N, et al. Impact of race on breast cancer in lower socioeconomic status women. Breast J. 2006;12(1):58–62.
doi: 10.1111/j.1075-122X.2006.00184.x
Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.
doi: 10.1093/jnci/94.5.334
Bickell NA, et al. Lost opportunities: physicians’ reasons and disparities in breast cancer treatment. J Clin Oncol. 2007;25(18):2516–21.
doi: 10.1200/JCO.2006.09.5539
Kovar A, et al. The waiting game: how long are breast cancer patients waiting for definitive diagnosis? Ann Surg Oncol. 2020;27(10):3641–9.
doi: 10.1245/s10434-020-08484-9
Harness JK, et al. Developing a comprehensive breast center. Am Surg. 1987;53(8):419–23.
pubmed: 3605861
Selby P, Gillis C, Haward R. Benefits from specialised cancer care. Lancet. 1996;348(9023):313–8.
doi: 10.1016/S0140-6736(96)02482-8
Chao AH, et al. Processes of care in breast reconstruction and the long-term impact of a comprehensive breast center. Ann Surg Oncol. 2015;22(Suppl 3):S1256–62.
doi: 10.1245/s10434-015-4811-x
Chao AH, et al. Process outcomes in breast reconstruction and the impact of a comprehensive breast center. Plast Reconstr Surg. 2014;134(5):675e–81e.
doi: 10.1097/PRS.0000000000000614
Wheeler SB, et al. Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients. Breast Cancer Res Treat. 2012;133(1):333–45.
doi: 10.1007/s10549-012-1955-2
Carpenter WR, et al. The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care. 2011;49(2):172–9.
doi: 10.1097/MLR.0b013e3182028ff2
Kinlock BL, et al. Racial disparity in time between first diagnosis and initial treatment of prostate cancer. Cancer Control. 2016;23(1):47–51.
doi: 10.1177/107327481602300108
Newman LA. Breast cancer disparities: socioeconomic factors versus biology. Ann Surg Oncol. 2017;24(10):2869–75.
doi: 10.1245/s10434-017-5977-1
Lett E, Asabor E, Beltrán S, Michelle Cannon A, Arah OA. Conceptualizing, contextualizing, and operationalizing race in quantitative health sciences research. The Annals of Family Medicine. 2022;20(2):157–63. https://doi.org/10.1370/afm.2792 .
doi: 10.1370/afm.2792
pubmed: 35045967
Flannigan A, et al. The reporting of race and ethnicity in medical and science journals. JAMA. 2021;325(11):1049–52.
doi: 10.1001/jama.2021.2104
Scott SE, et al. The model of pathways to treatment: conceptualization and integration with existing theory. Br J Health Psychol. 2013;18(1):45–65.
doi: 10.1111/j.2044-8287.2012.02077.x
Gagliato D, Lei X, Giordano S, et al. Impact of delayed neoadjuvant systemic chemotherapy on overall survival among patients with breast cancer. The Oncologist. 2020;25(9):749–57.
doi: 10.1634/theoncologist.2019-0744
Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148(6):516–23. https://doi.org/10.1001/jamasurg.2013.1680 .
doi: 10.1001/jamasurg.2013.1680
pubmed: 23615681
Byers AL, et al. Application of negative binomial modeling for discrete outcomes: a case study in aging research. J Clin Epidemiol. 2003;56(6):559–64.
doi: 10.1016/S0895-4356(03)00028-3
Ward WH, et al. Preoperative delays in the treatment of DCIS and the associated incidence of invasive breast cancer. Ann Surg Oncol. 2020;27(2):386–96.
doi: 10.1245/s10434-019-07844-4
McGee SA, et al. Determinants of breast cancer treatment delay differ for African American and White women. Cancer Epidemiol Biomarkers Prev. 2013;22(7):1227–38.
doi: 10.1158/1055-9965.EPI-12-1432
Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med. 2006;42(6):401–8.
doi: 10.1016/j.ypmed.2006.03.002
Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology. 2005;14(7):517–34.
doi: 10.1002/pon.864
Olaya W, Wong JH, Morgan JW, Roy-Chowdhury S, Lum SS. Disparities in the surgical management of women with stage I breast cancer. Am Surg. 2009;75(10):869–72.
doi: 10.1177/000313480907501001
Hershman DL, Buono D, Jacobson JS, et al. Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer. Ann Surg. 2009;249(5):828–33. https://doi.org/10.1097/SLA.0b013e3181a38f6f .
doi: 10.1097/SLA.0b013e3181a38f6f
pubmed: 19387318
Lautner M, et al. Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg. 2015;150(8):778–86.
doi: 10.1001/jamasurg.2015.1102
Samiian L, et al. The effect of insurance and race on breast cancer tumor biology and short-term outcomes. Am Surg. 2018;84(7):1223–8.
doi: 10.1177/000313481808400743
Cole AP, et al. Comparing the association between insurance and mortality in ovarian, pancreatic, lung, colorectal, prostate, and breast cancers. J Natl Compr Canc Netw. 2019;17(9):1049–58.
doi: 10.6004/jnccn.2019.7296
Hsu CD, et al. Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old. Cancer. 2017;123(16):3125–31.
doi: 10.1002/cncr.30722
Ko NY, et al. Association of insurance status and racial disparities with the detection of early-stage breast cancer. JAMA Oncol. 2020;6(3):385–92.
doi: 10.1001/jamaoncol.2019.5672
Franzoi MA, et al. Differences in breast cancer stage at diagnosis by ethnicity, insurance status, and family income in young women in the USA. J Racial Ethn Health Disparities. 2019;6(5):909–16.
doi: 10.1007/s40615-019-00591-y
Pilewskie M, et al. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol. 2014;21(5):1552–60.
doi: 10.1245/s10434-013-3424-5
Davis KL, et al. Use of MRI in preoperative planning for women with newly diagnosed DCIS: risk or benefit? Ann Surg Oncol. 2012;19(10):3270–4.
doi: 10.1245/s10434-012-2548-3
Expert Panel on Breast Imagin, et al. ACR Appropriateness Criteria((R)) breast cancer screening. J Am Coll Radiol. 2017;14(11S):S383–90.
Lamb LR, et al. Ductal carcinoma in situ (dcis) at breast MRI: predictors of upgrade to invasive carcinoma. Acad Radiol. 2020;27(10):1394–9.
doi: 10.1016/j.acra.2019.09.025
Ernster VL, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546–54.
doi: 10.1093/jnci/94.20.1546
Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):139–41.
doi: 10.1093/jncimonographs/lgq027
Nelson HD, Cantor A, Wagner J, et al. Effectiveness of patient navigation to increase cancer screening in populations adversely affected by health disparities: a meta-analysis. J Gen Intern Med. 2020;35(10):3026–35. https://doi.org/10.1007/s11606-020-06020-9 .
doi: 10.1007/s11606-020-06020-9
pubmed: 32700218
pmcid: 7573022
Enomoto LM, Fenstermaker J, Desnoyers RJ, et al. Oncology navigation decreases time to treatment in patients with pancreatic malignancy. Ann Surg Oncol. 2019;26(5):1512–8. https://doi.org/10.1245/s10434-019-07157-6 .
doi: 10.1245/s10434-019-07157-6
pubmed: 30652224
Flores G. The impact of medical interpreter services on the quality of health care: a systematic review. Med Care Res Rev. 2005;62(3):255–99. https://doi.org/10.1177/1077558705275416 .
doi: 10.1177/1077558705275416
pubmed: 15894705
Gomez CA, Kleinman DV, Pronk N, et al. Addressing health equity and social determinants of health through healthy people 2030. J Public Health Manag Pract Nov-Dec. 2021;27(Suppl 6):S249–57. https://doi.org/10.1097/PHH.0000000000001297 .
doi: 10.1097/PHH.0000000000001297
Giroir BP. Healthy people 2030: a call to action to lead America to healthier lives. J Public Health Manag Pract Nov-Dec. 2021;27(Suppl 6):S222–4. https://doi.org/10.1097/PHH.0000000000001266 .
doi: 10.1097/PHH.0000000000001266